Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 12, 2018 10:00 ET | Source: Trivedi Global, Inc.

Trivedi Global, Inc. Announces Research by Jay Prague on Energy Treated Vitamin D3 which Shows Significant Benefits for Bone Health

Houston, Texas, USA, July 12, 2018 (GLOBE NEWSWIRE) -- Jay A. Prague, an evidence-based healer, today released research results from preclinical trials on the beneficial impact of biofield energy...
July 12, 2018 09:30 ET | Source: Trivedi Global, Inc.

Trivedi Global, Inc. and Sally Henderson Announce Research Results on the Impact of a Biofield Energy Enhanced Nutraceutical to Improve Immune Function Response and Combat Inflammation

Iowa City, Iowa, USA, July 12, 2018 (GLOBE NEWSWIRE) -- Sally Jean Henderson, a scientifically validated energy healer, today announces research results based on the impact of a biofield energy...
July 12, 2018 09:00 ET | Source: Trivedi Global, Inc.

Trivedi Global, Inc. and James Jeffery Peoples Announce Research Results on the Impact of a Biofield Energy Treated Nutraceutical on Anti-Aging, Anti-Wrinkling, and Overall Skin Health

Cambridge, Massachusetts,, July 12, 2018 (GLOBE NEWSWIRE) -- James Jeffery Peoples, an evidence-based energy healer, announces today scientific research results on the significant impact of a...
July 12, 2018 08:30 ET | Source: National Hospice and Palliative Care Organization

NHPCO Releases Updated Edition of "Standards of Practice for Hospice Programs"

Alexandria, Va, July 12, 2018 (GLOBE NEWSWIRE) -- With the growth and visibility of hospice care in the U.S., it is essential that hospice organizations offer the highest levels of quality care and...
July 12, 2018 08:00 ET | Source: Pfenex, Inc.

Pfenex Receives Milestone From Merck Associated With Clinical Advancement of Investigational 15-valent Pneumococcal Vaccine PCV-15 (V114)

SAN DIEGO, July 12, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE AMERICAN:PFNX) today announced the receipt of a milestone payment from Merck associated with the initiation of the first Phase 3...
July 12, 2018 08:00 ET | Source: Catalyst Biosciences, Inc.

Catalyst Biosciences Announces Multiple Presentations at the Scientific and Standardization Committee Meeting of the International Society on Thrombosis and Haemostasis

Conference call and webcast to be held Wednesday, July 18, 2018 at 8:30 a.m. EDT SOUTH SAN FRANCISCO, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a...
July 12, 2018 08:00 ET | Source: BioBridge Global

BioBridge Global Announces Formation of Regenerative Medicine Advisory Board

San Antonio, Texas, July 12, 2018 (GLOBE NEWSWIRE) -- BioBridge Global today announced the formation of a new Regenerative Medicine Advisory Board, composed of industry leaders with a wide range of...
July 12, 2018 07:00 ET | Source: Zogenix, Inc.

Zogenix Announces Positive Top-line Results from Second Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome

Primary Endpoint Achieved - Statistically Significant Convulsive Seizure Reduction for ZX008 versus Placebo for Adjunctive Treatment of Seizures ZX008 Also Demonstrated Statistical Significance in...
July 12, 2018 07:00 ET | Source: Asterias Biotherapeutics

Asterias Biotherapeutics Announces New Exclusive License Agreement with The Regents of the University of California for Stroke IP; Second Pre-Clinical Collaboration Initiated to Test the Efficacy of AST-OPC1 for the Treatment of Stroke

FREMONT, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American:AST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological...
July 12, 2018 06:00 ET | Source: Progressive Markets

Global Patient Data Management Systems Market Expected to Reach $1,115.6 Million, by 2025

Pune, July 12, 2018 (GLOBE NEWSWIRE) -- According to a new report published by Progressive Markets Report, titled, "Global Patient Data Management Systems Market by Product, Mode of Delivery,...